Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 11, 2023 (3 years ago)

Capsaicin Cream 0.025%

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Product mix-up: Cartons labeled Capsaicin Cream 0.025% may contain tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Capsaicin Cream 0.025%, External Analgesic Cream, Penetrating Pain Relief, NET WT. 2.1 OZ. (60g) NDC 50268-195-60, Manufactured for: AvKARE, Pulaski, TN 38478

Affected NDC 50268-0195-60

Compare with the code on your package — it is the most precise check available.

Drug: Capsaicin

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Capsaicin External Analgesic
Capsaicin
NDC 50268-0195
.25 mg/g Cream
Topical
AvPAK OTC
Recalling firm
Avkare LLC
NDC code
50268-195-60
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1147-2023 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Capsaicin recalls

See all
Class II · Moderate risk

Natural Pain Relieving Cream

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0529-2024
Class II · Moderate risk

Pain Wizard

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0528-2024
Class II · Moderate risk

Natural Pain Relieving Cream

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0527-2024

Other recalls by Avkare LLC

All 2023 recalls
Class II · Moderate risk

Amantadine HCl

Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.

Ongoing Dissolution failure AvKARE NDC 50268-069-15 D-0341-2026